<DOC>
	<DOCNO>NCT02881216</DOCNO>
	<brief_summary>This study seek compare procedural performance new coronary stent generation , already available Germany , hitherto establish current drug-eluting stent .</brief_summary>
	<brief_title>Procedural Advantages Novel Drug-Eluting Coronary Stent</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Imidacloprid</mesh_term>
	<criteria>CAD PCI , consecutive patient Age 18 Bare Metal Stents Scaffolds</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>